• ABPI Website
  • Media
  • ABPI response to Life Sciences Innovative Manufacturing Fund announcement

ABPI response to Life Sciences Innovative Manufacturing Fund announcement

The Office for Life Sciences has today announced the £60million Life Sciences Innovative Manufacturing Fund, designed to boost medical manufacturing in the UK, as well as £200million to support access to data for health research. 

The full Government release is here

In response to the £60million Manufacturing Fund, ABPI Chief Executive Richard Torbett said: 

“This announcement will strengthen our sector and help the government realise its Vision for Life Sciences. Such funding was called for by our members, who are keen to invest in the latest manufacturing technologies in the UK.

Investing in hi-tech, UK manufacturing has never been more important. We look forward to hearing more about how the Fund will work and continuing to work with Government to make a real difference to UK growth as well as resilience to future pandemics and climate change.”


In response to the £200million to support better access to NHS data for research, ABPI Executive Director of Strategy, Research and Partnerships Colette Goldrick said: 

“This substantial investment in developing and building public confidence in the UK’s health data infrastructure is very welcome. Health data has been critical in the fight against COVID-19, and more people than ever before have seen the benefits that sharing information can bring in terms of researching and developing new treatments at unprecedented speed.

“We look forward to this funding, once confirmed, strengthening the UK’s health data assets to unlock a new generation of medical breakthroughs.” 

  • Manufacturing

Last modified: 20 September 2023

Last reviewed: 20 September 2023

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.